30
Participants
Start Date
June 24, 2020
Primary Completion Date
June 30, 2021
Study Completion Date
September 30, 2021
Apremilast 30mg
30mg PO BID started within 10 days of baseline
calcipotriene and betamethasone dipropionate
1 application daily starting at baseline and continuing for 4 weeks; those achieving clear or almost clear PGA at week 4 will continue application twice weekly on Monday and Thursday in combination with Otezla. Enstilar application is discontinued at week 16 and study participation continues until week 20.
RECRUITING
Skin Sciences, PLLC, Louisville
Lead Sponsor
Derm Research, PLLC
OTHER